Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.
about
Follow-up care for survivors of lymphoma who have received curative-intent treatmentNext-generation surveillance strategies for patients with lymphomaUtility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma.Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker studyPrognostic value of interim (18)F-FDG-PET in diffuse large B cell lymphoma treated with rituximab-based immune-chemotherapy: a systematic review and meta-analysis.Dynamic monitoring of circulating tumor DNA in non-Hodgkin lymphoma.When should FDG-PET be used in the modern management of lymphoma?Role of routine imaging in detecting recurrent lymphoma: A review of 258 patients with relapsed aggressive non-Hodgkin and Hodgkin lymphoma.The utility and limitations of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review.PET-CT in Staging, Response Evaluation, and Surveillance of Lymphoma.Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.Evaluating surveillance imaging for diffuse large B-cell lymphoma and Hodgkin lymphoma.Surveillance Scans in Lymphoma: Friend or Foe?Adding weight to a sinking ship: more reasons not to perform routine surveillance imaging in patients with diffuse large B-cell lymphoma in remission.R-CHOP(-like) treatment of diffuse large B-cell lymphoma significantly reduces CT-assessed vertebral bone density: a single center study of 111 patients.Frequency of surveillance computed tomography in non-Hodgkin lymphoma and the risk of secondary primary malignancies: A nationwide population-based study.Symptom-oriented clinical detection versus routine imaging as a monitoring policy of relapse in patients with diffuse large B-cell lymphoma.
P2860
Q28077086-080F22F0-2DA9-40DA-9256-E5AC1AC701A6Q28084956-324F1D95-395E-436D-887D-9F80C451AA54Q34402503-15D5A838-CB7F-4A8D-AA57-4D2AD49D9045Q35700203-C37ED7F4-D038-4023-8413-077DE35E445EQ35858346-B764C536-22CC-4B9D-9F21-675119D45AEFQ37035820-5C818F85-222A-45B6-AF38-1D2576505FA2Q38153086-7B5AFC19-AC7F-4400-8D66-2FB715A9FA4BQ38184954-CA65E611-A092-4B27-8B2E-32F8CA3C87A8Q38203924-1637BC43-E43E-4438-8B28-4C68A856F00DQ38794783-5998C231-D40D-4137-9D6B-8D10902D6D81Q38909384-1A8D2660-B198-41CB-932B-38A073D12A97Q39036785-986243A3-5AB4-464F-96B7-610DAEDD647CQ39142301-E1E32806-85EB-43E1-AC69-E65B41A7DC61Q47189782-10543D62-594F-4EA9-AED8-06946DEC1B61Q47982342-F44968AD-0512-4A24-A41D-0F3068AD1378Q48126796-FFB1A72F-23D6-4474-82E5-1A83A3E22184Q53083174-7DCA566B-E937-4E48-9850-E73BDDB5C54D
P2860
Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Limited role for surveillance ...... ion following primary therapy.
@en
Limited role for surveillance ...... ion following primary therapy.
@nl
type
label
Limited role for surveillance ...... ion following primary therapy.
@en
Limited role for surveillance ...... ion following primary therapy.
@nl
prefLabel
Limited role for surveillance ...... ion following primary therapy.
@en
Limited role for surveillance ...... ion following primary therapy.
@nl
P2093
P2860
P50
P356
P1476
Limited role for surveillance ...... sion following primary therapy
@en
P2093
D A Carney
D S Ritchie
D Westerman
H Januszewicz
H M Prince
J F Seymour
M Dickinson
P2860
P2888
P304
P356
10.1038/BJC.2013.338
P407
P577
2013-06-27T00:00:00Z